Table 2.
Group
(n=8) |
Treatment |
Dose
(mg/kg) |
liver parameters
(mg/dl)
|
||||
---|---|---|---|---|---|---|---|
ALP | ALT | AST | Total bilirubin | Total protein | |||
1 | N+C | 10 ml/kg | 99.08±6.17 | 52.62±3.08 | 39.86±4.97 | 1.59±0.13 | 7.51±0.41 |
2 | N+B | 500 | 91.42±2.17 | 50.18±5.01 | 35.18±5.09 | 1.30±0.11 | 7.53±0.44 |
3 | D+C | 10 ml/kg | 178.81±6.40# | 99.88±4.84# | 94.18±4.42# | 3.71±0.16# | 3.97±0.28# |
4 | D+Bb | 500 | 95.10±5.20c | 46.05±3.55c | 35.58±4.40c | 1.81±0.11c | 5.70±0.29a |
5 | D+Ba | 500 | 127.76±9.58c* | 66.91±3.91c* | 65.40±6.50b** | 2.74±0.19b** | 3.86±0.26* |
D+Bb : Diabetic rats treated + barberry_ before. D+Ba : Diabetic rats + Barberry_ After.;Nnormal;Ccontrol;B barberry: D diabetic; Values are presented as mean ± S.E.M..; n = 8 in each group. One way ANOVA followed by tukeytest;.
p<0.001 Diabetic control Rats were compared with Normal control Rats.
p<0.05 and
p<0.01,
p<0.001 Diabetic treated Rats were compared with Diabetic control Rats;
p<0.05 and
p<0.01 : Diabetic rats + Barberry_ After were compared with Diabetic rats treated + barberry_ before.